GeoPolitics Pulse

The Heartbeat of World events

Amgen’s IMDYLLTRA® (tarlatamab) Granted a Conditional Marketing Authorisation for …

by ·

… United Kingdom. IMDYLLTRA® is indicated for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease …Read More

Related posts:

  1. European Commission grants conditional marketing authorization to Pfizer’s gene therapy …
  2. EU withdraws marketing authorisation for Abbvie’s hepatitis C drug – Reuters
  3. Tarlatamab Earns UK Approval for Previously Treated ES-SCLC – OncLive
  4. Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United …
  5. Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United …